Full listing of cancer treatment and drug information at your fingertips
Quickly locate frequently updated trials by cancer type, stage, location and more
Easy access to an extensive range of current and concise drug information
The preliminary rate of lung cancer diagnosis using low-dose computed tomography (CT) screening is 7% at a Veterans Affairs Medical Center.
Initial results from the National Lung Screening Trial concur with the literature, with more positive screening results, diagnostic procedures, and lung cancers detected with low-dose CT versus chest radiography screening.
Among men with nonmetastatic prostate cancer the risk for other-cause mortality increases with the number of comorbid conditions, particularly in older men.
Although further safety data is needed, endoscopic ultrasound may prove to be an effective way of administering localized chemotherapy.
Obesity not only increases risk for diabetes and cardiovascular diseases; it can also be a risk factor for many types of cancer.
Chief Complaint
DC, a 54-year-old male diagnosed with multiple myeloma, develops a low grade fever and some mild diarrhea 10 days ...
Chief Complaint
AG, 64-year-old gentleman of Greek descent, presents with a 6-month history of rash that started on his upper extremities ...
Tara Morrison, MD, Advisory Board member, shares the case of a 66-year-old African American man with weight loss and pain around the abdomen.
Advisory Board member Martin S. Tallman, MD, shares the unusual case of a patient with pancytopenia.
Barbara Ann Burtness, MD
Steven Cohen, MD
E. David Crawford, MD
Jeffrey M. Farma, MD
Eric Feldman, MD
Sergio A. Giralt, MD
Todd Morgan, MD
Edith A. Perez, MD
Neal D. Shore, MD, FACS
Mark A. Socinski, MD
Martin Tallman, MD
Adelle Berezinsky, PharmD
Kimberly A. Bracey, MBA/MSN/HCM, OCN
Inez Brandon, MSN
Sandra Cuellar, PharmD, BCOP
Jeanne Held-Warmkessel, MSN
Anna Hitron, PharmD, MS, BCOP
Thomas P. Lynch, Jr. BSPharm, BCOP
Ali McBride, MS, PharmD
Ayman Saad, MD
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |